Skip to main content
Shalby Limited logo

Shalby Limited — Investor Relations & Filings

Ticker · SHALBY ISIN · INE597J01018 LEI · 335800RVKD2F29DRCR78 BSE.NS Human health and social work activities
Filings indexed 793 across all filing types
Latest filing 2020-08-11 AGM Information
Country IN India
Listing BSE.NS SHALBY

About Shalby Limited

https://www.shalby.org

Shalby Limited is a multi-specialty organization recognized for its expertise in orthopedics and joint replacement surgery. The entity operates a network of facilities offering comprehensive medical services, including cardiology, oncology, neurology, and nephrology. It is distinguished by its high volume of orthopedic procedures and the implementation of the "Zero Technique" for knee replacements, designed to minimize surgical duration and accelerate patient recovery. In addition to clinical care, the organization maintains a presence in the orthopedic implant sector through its manufacturing division, which produces specialized implants and surgical instrumentation. The group focuses on providing tertiary and quaternary care utilizing advanced diagnostic and therapeutic infrastructure to serve a diverse patient base.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a newspaper advertisement for the 16th Annual General Meeting (AGM) of Shalby Limited. It mentions compliance with SEBI regulations and the Ministry of Corporate Affairs circular, and provides details about the AGM date and e-voting information. The document does not contain financial statements, management discussion, or detailed report content, but rather is an announcement related to the AGM event and its notice publication. The document length is short (1866 characters), and it is primarily an announcement of the AGM notice publication. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related notices.
2020-08-11 English
Date of payment of dividend
AGM Information Classification · 95% confidence The document is an intimation letter dated August 10, 2020, addressed to stock exchanges and shareholders. It announces the scheduling of the 16th Annual General Meeting (AGM) of the company, including details such as the book closure period, e-voting dates, dividend payment date, and other procedural information. It references the upcoming AGM and mentions that the Notice of the 16th AGM along with the Annual Report for FY 2019-20 will be sent later. The document does not contain the actual Annual Report or financial statements but is an announcement related to the AGM and associated shareholder information. The document length is 3669 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R) as it provides materials and information related to the Annual General Meeting but is not the report itself.
2020-08-10 English
Book Closure
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges regarding the book closure dates for the purpose of the 16th Annual General Meeting and dividend entitlement for the financial year 2019-20. It mentions the dates for book closure and the cut-off date for dividend eligibility. The document is an announcement related to shareholder meeting logistics and dividend payment, not the actual AGM materials, annual report, or dividend declaration itself. It is a regulatory announcement informing the exchanges and shareholders about the book closure period. The document length is short (2515 characters) and it does not contain financial statements or detailed report content. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement related to compliance with SEBI regulations.
2020-08-10 English
Updates
AGM Information Classification · 95% confidence The document is an official communication from Shalby Limited to stock exchanges and regulatory bodies regarding the scheduling and details of the 16th Annual General Meeting (AGM). It includes information about the AGM date, book closure period, e-voting dates, dividend payment date, and other procedural details. It explicitly states that the Notice of the 16th AGM along with the Annual Report for FY 2019-20 will be sent later and disseminated on websites. The document itself is not the Annual Report or the AGM materials but an intimation or announcement about the AGM and related procedural information. The document length is 3677 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R), as it provides information related to the Annual General Meeting but does not contain the full report or presentation materials.
2020-08-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the attendance of company management at an investor/analyst conference call. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document explicitly states that the management attended a conference call but did not discuss any price sensitive information. There is no detailed transcript of the call, no financial data, and no substantive discussion of results or outlook. The document is essentially an announcement of the occurrence of a conference call, not the call transcript itself. Given the short length (1813 characters) and the nature of the content, this fits best as a Regulatory Filing (RNS) rather than a Call Transcript (CT) or any other category. It is not a report or presentation, nor a voting or capital change announcement.
2020-07-25 English
Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure filed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates listed companies to inform the stock exchanges about material events or information. The content focuses on the impact of the COVID-19 pandemic on the company's business operations, including operational status, financial impact, and steps taken. It is not a full financial report, earnings release, or management discussion but rather an update on a material event affecting the company. The document is addressed to stock exchanges and includes a compliance officer's signature, consistent with a regulatory announcement. Therefore, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-07-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.